Trial Profile
Efficacy and Safety of Telbivudine in Preventing Mother-to-infant HBV Transmission in HBV-infected Pregnant Women in Immune Tolerant Phase
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 Dec 2015 New trial record